Mercaptamine
Cystagon, Procysbi (cysteamine) is a small molecule pharmaceutical. Cysteamine was first approved as Cystagon on 1994-08-15. It is used to treat cystinosis in the USA. Cystagon's patents are valid until 2036-08-16 (FDA).
Trade Name | Cystagon, Procysbi |
---|---|
Common Name | Mercaptamine |
Indication | cystinosis |
Drug Class |